Specific expression of human interferon-gamma controls hepatitis B virus replication in vitro in secreting hepatitis B surface antigen hepatocytes

Journal of Virological Methods

Volumn 180, Issue 1-2, 2012, Pages 84-90

  Kan, Quancheng ^a   Li, Duolu ^a   Yu, Zujiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Antiviral; Gene regulation; Hepatitis B virus; Interferon ; PcDNA3.1

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; CORE PROTEIN; DNA FRAGMENT; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN;

ANTIGEN EXPRESSION; ANTISENSE THERAPY; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOTOXICITY; EXPRESSION VECTOR; GENE TRANSFER; GENETIC TRANSDUCTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS GENE; VIRUS REPLICATION;

ANTIVIRAL AGENTS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENETIC VECTORS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; INTERFERON-GAMMA; PLASMIDS; VIRUS REPLICATION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84862778674     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.12.016     Document Type: Article

References (20)

1. Abdelhamed A.M., Kelley C.M., Miller T.G., Furman P.A., Isom H.C. Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment. J. Virol. 2002, 76:8148-8160.
2. Aurisicchio L., Bujard H., Hillen W., Cortese R., Ciliberto G., la Monica N., Palombo F. Regulated and prolonged expression of mIFN(alpha) in immunocompetent mice mediated by a helper-dependent adenovirus vector. Gene Ther. 2001, 8:1817-1825.
3. Aurisicchio L., de Tomassi A., la Monica N., Ciliberto G., Traboni C., Palombo F. Regulated and liver-specific tamarin alpha interferon gene delivery by a helper-dependent adenoviral vector. J. Virol. 2005, 79:6772-6780.
4. Chu C.M. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2000, 15(Suppl.):E25-E30.
5. Chu C.M., Liaw Y.F. Natural history of chronic hepatitis B virus infection: an immunopathological study. J. Gastroenterol. Hepatol. 1997, 12:S218-S222.
6. Dumortier J., Schonig K., Oberwinkler H., Low R., Giese T., Bujard H., Schirmacher P., Protzer U. Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice. Gene Ther. 2005, 12:668-677.
7. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 2001, 19:65-91.
8. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999, 284:825-829.
9. Hodgson P.D., Michalak T.I. Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection. Hepatology 2001, 34:1049-1059.
10. Horton R.M., Hunt H.D., Ho S.N. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 1989, 77:61-68.
11. Kan Q.C., Yu Z.J., Lei Y.C., Hao L.J., Yang D.L. Lethiferous effects of a recombinant vector carrying thymidine kinase suicide gene on 2.2.15 cells via a self-modulating mechanism. World J. Gastroenterol. 2003, 9:2216-2220.
12. Li D., Takyar S.T., Lott W.B., Gowans E.J. Amino acids 1-20 of the hepatitis C virus (HCV) core protein specifically inhibit HCV IRES-dependent translation in HepG2 cells, and inhibit both HCV IRES- and cap-dependent translation in HuH7 and CV-1 cells. J. Gen. Virol. 2003, 84:815-825.
13. Parvez M.K., Sehgal D., Sarin S.K., Basir S.F., Jameel S. Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma. World J. Gastroenterol. 2006, 12:3006-3014.
14. Reifenberg K., Hildt E., Lecher B., Wiese E., Nusser P., Ott S., Yamamura K., Rutter G., Lohler J. IFNgamma expression inhibits LHBs storage disease and ground glass hepatocyte appearance, but exacerbates inflammation and apoptosis in HBV surface protein-accumulating transgenic livers. Liver Int. 2006, 26:986-993.
15. Roman S., Panduro A., Aguilar-Gutierrez Y., Maldonado M., Vazquez-Vandyck M., Martinez-Lopez E., Ruiz-Madrigal B., Hemandez-Nazara Z. A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review. Hepatol. Int. 2009, 3:343-355.
16. Sasagawa T., Hlaing M., Akaike T. Synergistic induction of apoptosis in murine hepatoma Hepa1-6 cells by IFN-gamma and TNF-alpha. Biochem. Biophys. Res. Commun. 2000, 272:674-680.
17. Schultz U., Chisari F.V. Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes. J. Virol. 1999, 73:3162-3168.
18. Shi H., Guan S.H. Increased apoptosis in HepG2.2.15 cells with hepatitis B virus expression by synergistic induction of interferon-gamma and tumour necrosis factor-alpha. Liver Int. 2009, 29:349-355.
19. Shimoike T., Koyama C., Murakami K., Suzuki R., Matsuura Y., Miyamura T., Suzuki T. Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein. Virology 2006, 345:434-445.
20. Zhang J., Yamada O., Yoshida H., Iwai T., Araki H. Autogenous translational inhibition of core protein: implication for switch from translation to RNA replication in hepatitis C virus. Virology 2002, 293:141-150.